Viewing Study NCT04442269


Ignite Creation Date: 2025-12-24 @ 10:48 PM
Ignite Modification Date: 2025-12-30 @ 6:37 PM
Study NCT ID: NCT04442269
Status: COMPLETED
Last Update Posted: 2025-04-04
First Post: 2020-06-04
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Investigating Treatment With Dupilumab in Patients With Allergic Bronchopulmonary Aspergillosis (ABPA) (LIBERTY ABPA AIRED)
Sponsor: Regeneron Pharmaceuticals
Organization: